BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 651945)

  • 1. Lidocaine kinetics predicted by indocyanine green clearance.
    Zito RA; Reid PR
    N Engl J Med; 1978 May; 298(21):1160-3. PubMed ID: 651945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lidocaine kinetics: relationships between early lidocaine kinetics and indocyanine green clearance.
    Zito RA; Reid PR
    J Clin Pharmacol; 1981; 21(2):100-5. PubMed ID: 7229115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Continuous infusion of lidocaine in patients with cardiac arrhythmias. Unpredictability of plasma concentrations.
    Sawyer DR; Ludden TM; Crawford MH
    Arch Intern Med; 1981 Jan; 141(1):43-5. PubMed ID: 7447583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lignocaine and indocyanine green kinetics in patients following myocardial infarction.
    Bax ND; Tucker GT; Woods HF
    Br J Clin Pharmacol; 1980 Oct; 10(4):353-61. PubMed ID: 7448106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of H2-receptor antagonists on steady-state extraction of indocyanine green and lidocaine by the perfused rat liver.
    Roberts RK; Heath CA; Johnson RF; Speeg KV; Schenker S
    J Lab Clin Med; 1986 Feb; 107(2):112-7. PubMed ID: 2868064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simultaneous measurement of effective hepatic blood flow and systemic circulation.
    Hashimoto M; Watanabe G
    Hepatogastroenterology; 2000; 47(36):1669-74. PubMed ID: 11149029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The estimation of hepatic blood flow with indocyanine green: comparison between the continuous infusion and single injection methods.
    Villeneuve JP; Huot R; Marleau D; Huet PM
    Am J Gastroenterol; 1982 Apr; 77(4):233-7. PubMed ID: 7072694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma elimination of indocyanine green in the intact pig after bolus injection and during constant infusion: comparison of spectrophotometry and high-pressure liquid chromatography for concentration analysis.
    Ott P; Keiding S; Bass L
    Hepatology; 1993 Dec; 18(6):1504-15. PubMed ID: 8244277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetic study on the hepatic uptake of indocyanine green in cirrhotic patients.
    Kawasaki S; Sugiyama Y; Iga T; Hanano M; Sanjo K; Beppu T; Idezuki Y
    Am J Gastroenterol; 1985 Oct; 80(10):801-6. PubMed ID: 4036939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapy with antiarrhythmic drugs.
    Goldman P; Ingelfinger JA
    N Engl J Med; 1978 May; 298(21):1193-4. PubMed ID: 651949
    [No Abstract]   [Full Text] [Related]  

  • 11. Determination of hepatic blood flow in the rat using sequential infusions of indocyanine green or galactose.
    Pollack GM; Brouwer KL; Demby KB; Jones JA
    Drug Metab Dispos; 1990; 18(2):197-202. PubMed ID: 1971573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of liver blood flow on the pharmacokinetics of tissue-type plasminogen activator (alteplase) during thrombolysis in patients with acute myocardial infarction.
    van Griensven JM; Koster RW; Burggraaf J; Huisman LG; Kluft C; Kroon R; Schoemaker RC; Cohen AF
    Clin Pharmacol Ther; 1998 Jan; 63(1):39-47. PubMed ID: 9465840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of hypotension on liver blood flow and lidocaine disposition.
    Feely J; Wade D; McAllister CB; Wilkinson GR; Robertson D
    N Engl J Med; 1982 Sep; 307(14):866-9. PubMed ID: 7110261
    [No Abstract]   [Full Text] [Related]  

  • 14. Influence of viral hepatitis on the disposition of two compounds with high hepatic clearance: lidocaine and indocyanine green.
    Williams RL; Blaschke TF; Meffin PJ; Melmon KL; Rowland M
    Clin Pharmacol Ther; 1976 Sep; 20(3):290-9. PubMed ID: 954351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of anesthetic agents and abdominal surgery on liver blood flow.
    Cowan RE; Jackson BT; Grainger SL; Thompson RP
    Hepatology; 1991 Dec; 14(6):1161-6. PubMed ID: 1959866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of route of administration and blood flow on hepatic drug elimination.
    Shand DG; Kornhauser DM; Wilkinson GR
    J Pharmacol Exp Ther; 1975 Dec; 195(3):424-32. PubMed ID: 1195129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of hepatic plasma flow on alfentanil plasma concentration plateaus achieved with an infusion model in humans: measurement of alfentanil hepatic extraction coefficient.
    Chauvin M; Bonnet F; Montembault C; Levron JC; Viars P
    Anesth Analg; 1986 Oct; 65(10):999-1003. PubMed ID: 2875679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lidocaine infusions: effect of duration and method of discontinuation on recurrence of arrhythmias and pharmacokinetic variables.
    Fredrick DS; Boersma RB
    Am J Hosp Pharm; 1979 Jun; 36(6):778-81. PubMed ID: 463893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of propofol and dexmedetomidine on indocyanine green elimination assessed with LIMON to patients with early septic shock: a pilot study.
    Memiş D; Kargi M; Sut N
    J Crit Care; 2009 Dec; 24(4):603-8. PubMed ID: 19931154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sorbitol as a test substance for measurement of liver plasma flow in humans.
    Keiding S; Engsted E; Ott P
    Hepatology; 1998 Jul; 28(1):50-6. PubMed ID: 9657096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.